The deal expands the pharmaceutical company’s portfolio of cancer drugs. Source link
The Federal Trade Commission said it had agreed to end its legal challenge of the $27.8 billion deal. The pact…
The move gives the agency time to weigh a settlement that would allow the deal to close with conditions. Source…
The deal would bolster the biotech company’s portfolio of treatments for neuromuscular and rare diseases. Source link
China remains attractive to global pharmaceutical companies even as many multinationals shift their focus elsewhere. Source link
Roivant, started by presidential candidate Vivek Ramaswamy, could seal a deal in coming days. Source link
Roivant, started by presidential candidate Vivek Ramaswamy, could seal a deal in coming days Source link
Stocks of developers of fatty liver disease treatments had been on a tear until results from Eli Lilly’s medication were…
Merck & Co. is in late-stage talks to acquire Prometheus Biosciences Inc., according to people familiar with the matter, a…